Skip to content
About
Expand
About
Lars Edvinsson
Board of directors
Management
Scientific advisory board
Research & development
Expand
Pioneering research
Mechanism of action
EDV2209
Results – Completed phase 1b/2a study
Clinical and regulatory path forward for the Phase 2b SAH study
Orphan Drug
Publications
Pipeline
Expand
Pipeline
aSAH – Subarachnoid haemorrhage
Thrombectomy in acute ischemic stroke
Investors
Expand
Strategy
Market opportunity
Intellectual Property
Shareholders
News
Toggle Menu
Extended Glasgow Outcome Scale
Contact
Medicon Village
223 81 Lund. Sweden
info@edvince.com
About
Toggle child menu
Expand
About
Lars Edvinsson
Board of directors
Management
Scientific advisory board
Research & development
Toggle child menu
Expand
Pioneering research
Mechanism of action
EDV2209
Results – Completed phase 1b/2a study
Clinical and regulatory path forward for the Phase 2b SAH study
Orphan Drug
Publications
Pipeline
Toggle child menu
Expand
Pipeline
aSAH – Subarachnoid haemorrhage
Thrombectomy in acute ischemic stroke
Investors
Toggle child menu
Expand
Strategy
Market opportunity
Intellectual Property
Shareholders
News